13.52 USD
+0.74 (+5.79%)
13.66 USD
+0.14 (+1.04%)
ChartMill assigns a Buy % Consensus number of 82% to VOR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 41.41. This target is 206.3% above the current price.
VOR was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about VOR.
In the previous month the buy percentage consensus was at a similar level.
VOR was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | Citigroup | Initiate | Buy |
| 2025-12-19 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-17 | TD Cowen | Initiate | Buy |
| 2025-12-09 | JP Morgan | Initiate | Overweight |
| 2025-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-15 | Baird | Upgrade | Neutral -> Outperform |
| 2025-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-30 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-06-27 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-26 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-05-09 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-05-09 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2025-03-21 | Stifel | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-06 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-13 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-10 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-23 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-21 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-03-21 | Stifel | Maintains | Buy -> Buy |
VOR BIOPHARMA INC / VOR FAQ
Can you provide the average price target for VOR BIOPHARMA INC stock?
10 analysts have analysed VOR and the average price target is 41.41 USD. This implies a price increase of 206.3% is expected in the next year compared to the current price of 13.52.
What is the consensus rating for VOR stock?
The consensus rating for VOR BIOPHARMA INC (VOR) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.